Approval · Notice of Compliance 7667 · 2005
METHOTREXATE: Notice of Compliance 7667
Issued December 22, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7667
- Date
- December 22, 2005
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update: additional safety information and new format
- Therapeutic class
- Antimetabolite
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METHOTREXATE | Not yet assigned | — |
Medicinal ingredients
- METHOTREXATE SODIUM 2.5 MG per TAB
- METHOTREXATE SODIUM 25 MG per ML